Cargando…

Concomitant cervical and transperineal parametrial high-dose-rate brachytherapy boost for locally advanced cervical cancer

PURPOSE: There is no consensus for parametrial boost technic while both transvaginal and transperineal approaches are discussed. A prototype was developed consisting of a perineal template, allowing transperineal needle insertion. This study analyzed acute toxicity of concomitant cervical and transp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bailleux, Caroline, Falk, Alexander Tuan, Chand-Fouche, Marie-Eve, Gautier, Mathieu, Barranger, Emmanuel, Hannoun-Levi, Jean-Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2016
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793065/ https://www.ncbi.nlm.nih.gov/pubmed/26985194 http://dx.doi.org/10.5114/jcb.2016.57535

Ejemplares similares

High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes
por: le Guyader, Maud, et al.
Publicado: (2021)

High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort
por: Marotte, Delphine, et al.
Publicado: (2022)

Interstitial high-dose rate brachytherapy as boost for anal canal cancer
por: Falk, Alexander Tuan, et al.
Publicado: (2014)

Prostate cancer boost using high-dose-rate brachytherapy: early toxicity analysis of 3 different fractionation schemes
por: Hijazi, Hussam, et al.
Publicado: (2013)

Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial
por: Hannoun-Levi, Jean-Michel, et al.
Publicado: (2022)

Dose gradient impact on equivalent dose at 2 Gy for high dose rate interstitial brachytherapy
por: Hannoun-Levi, Jean-Michel, et al.
Publicado: (2012)

Factors predictive of parametrial boost in patients with cervical cancer treated with definitive chemoradiation
por: Jamora, Kurl E., et al.
Publicado: (2022)

High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis
por: Rouscoff, Yohann, et al.
Publicado: (2014)

Second salvage treatment for local recurrence of prostate cancer using high-dose-rate brachytherapy: a case report
por: Claren, Audrey, et al.
Publicado: (2015)

The Relationship Between Parametrial Involvement and Parametrial Tissue Removed in Radical Surgery in Early-Stage Cervical Cancer
por: Birge, Ozer, et al.
Publicado: (2022)

High-dose rate brachytherapy in localized penile cancer: 5-Year clinical outcome analysis
por: Martz, Nicolas, et al.
Publicado: (2021)

Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal
por: Bertin, Emilien, et al.
Publicado: (2018)

Factors predicting parametrial invasion in patients with early-stage cervical carcinomas
por: Hsu, Heng-Cheng, et al.
Publicado: (2018)

Intracavitary/Interstitial Applicator Plus Distal Parametrial Free Needle Interstitial Brachytherapy in Locally Advanced Cervical Cancer: A Dosimetric Study
por: Qu, Hong-Da, et al.
Publicado: (2021)

Optimizing parametrial aperture design utilizing HDR brachytherapy isodose distribution
por: Chapman, Katherine L., et al.
Publicado: (2013)

Accelerated partial breast irradiation in the elderly: 5-year results of high-dose rate multi-catheter brachytherapy
por: Genebes, Caroline, et al.
Publicado: (2014)

Irradiation of localized prostate cancer in the elderly: A systematic literature review
por: Marotte, Delphine, et al.
Publicado: (2022)

Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer
por: Yamazaki, Hiroyuki, et al.
Publicado: (2015)

Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer
por: Chang, Hong, et al.
Publicado: (2023)

Brachytherapy for oligometastatic prostate cancer to the penis
por: Martz, Nicolas, et al.
Publicado: (2021)

Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
por: Lee, Tae Hoon, et al.
Publicado: (2021)

Identification of a low risk population for parametrial invasion in patients with early-stage cervical cancer
por: Dabi, Yohann, et al.
Publicado: (2018)

Nomogram Predicting Parametrial Involvement Based on the Radical Hysterectomy Specimens in the Early-Stage Cervical Cancer
por: Li, Chunbo, et al.
Publicado: (2021)

The Importance of Clinical Examination under General Anesthesia: Improving Parametrial Assessment in Cervical Cancer Patients
por: Sodeikat, Paulina, et al.
Publicado: (2021)

CyberKnife Boost for Patients with Cervical Cancer Unable to Undergo Brachytherapy
por: Haas, Jonathan Andrew, et al.
Publicado: (2012)

Nomogram Predicting the Likelihood of Parametrial Involvement in Early-Stage Cervical Cancer: Avoiding Unjustified Radical Hysterectomies
por: Benoit, Louise, et al.
Publicado: (2020)

iPMI: Machine Learning-Aided Identification of Parametrial Invasion in Women with Early-Stage Cervical Cancer
por: Charoenkwan, Phasit, et al.
Publicado: (2021)

What are the determinants of parametrial invasion in patients with early stage cervical cancer: A cross sectional study
por: Hoorshad, Niloufar, et al.
Publicado: (2022)

Prognostic analysis of uterine cervical cancer treated with postoperative radiotherapy: importance of positive or close parametrial resection margin
por: Kim, Yi-Jun, et al.
Publicado: (2015)

Five-year oncological outcome after a single fraction of accelerated partial breast irradiation in the elderly
por: Kinj, Rémy, et al.
Publicado: (2019)

Separate lateral parametrial lymph node dissection improves detection rate of parametrial lymph node metastasis in early-stage cervical cancer: 10-year clinical evaluation in a single center in China
por: Zhao, Dan, et al.
Publicado: (2020)

Proton Arc Therapy vs Interstitial HDR Brachytherapy in Gynecologic Cancer with Parametrial/pelvic Side Wall Extension
por: Yi, ByongYong, et al.
Publicado: (2022)

Brachytherapy Versus Stereotactic Body Radiotherapy for Cervical Cancer Boost: A Dosimetric Comparison
por: Dahbi, Zineb, et al.
Publicado: (2023)

Factors associated with parametrial involvement in patients with stage IB1 cervical cancer: Who is suitable for less radical surgery?
por: Lee, Seung-Ho, et al.
Publicado: (2018)

Percutaneous Parametrial Dose Escalation in Women with Advanced Cervical Cancer: Feasibility and Efficacy in Relation To Long-term Quality of Life
por: Akbaba, Sati, et al.
Publicado: (2018)

Postoperative chemoradiotherapy versus radiotherapy alone for elderly cervical cancer patients with positive margins, lymph nodes, or parametrial invasion
por: Cushman, Taylor R., et al.
Publicado: (2018)

Narrowing Resection of Parametrial Tissues Is Feasible in Low-Risk Cases of Stage IA2-IB1 Cervical Cancer
por: Li, Xue-Lian, et al.
Publicado: (2016)

Clinical results of external beam radiotherapy alone with a concomitant boost program or with conventional fractionation for cervical cancer patients who did not receive intracavitary brachytherapy
por: Matsuura, Kanji, et al.
Publicado: (2012)

Single fraction of accelerated partial breast irradiation in the elderly: early clinical outcome
por: Kinj, Rémy, et al.
Publicado: (2018)

Factors affecting parametrial involvement in cervical cancer patients with tumor size ≤4 cm and selection of low-risk patient group
por: Akıllı, Hüseyin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uf4lba5idh1fgv0jtrgdkfh5v9